drugset / Trial / NCT00812461

Efficacy of Nalmefene in Patients With Alcohol Dependence

NCT00812461

Phase 3 Completed 678 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy, safety and tolerability of nalmefene in the treatment of alcohol dependence.

Timeline

Start
2009-03
Primary completion
2011-03
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalmefene Small molecule 18.06 mg Oral

Indications